Eyedrop startup Nanodropper has closed on a $1.4 million seed round, it announced earlier this week.
The round included investments from New York City-based Golden Seeds Ventures, Rochester Area Economic Development, Inc., Austin Area Angels and Seattle-based Alliance of Angels.
Rochester-based Nanodropper was co-founded by CEO Allisa Song; Chief Commercialization Officer Mackenzie Andrews; Chief Scientific Officer Dr. Jennifer Steger; and Chief Operating Officer Elias Baker in Seattle. The company relocated to Rochester because Song is a medical student at the Mayo Clinic.
Nanodropper makes an eyedrop bottle adapter that reduces the size of an eyedrop by almost 70 percent, reducing medical waste. The dropper is FDA-listed and is commercially available on the startup's website and in clinics around the country.
"Our partner clinic network has already expanded to 16 states and Washington, D.C. With this new wave of support, we are ready to expand our reach to the entire U.S. and internationally," Song said in a statement.
Nanodropper has seven employees. It will use the venture cash it has raised to build out its marketing and sales, Nanodropper Marketing Manager Robbie Spencer said.
Nanodropper was the recent recipient of a Launch Minnesota grant. The co-founders of Nanodropper were also recently named to the 2021 Forbes "30 Under 30" list in the health care category.
